Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Platinum-based Chemotherapy With or Without Paclitaxel in Treating Patients With Relapsed Ovarian Cancer

This study has been completed.
Information provided by:
National Cancer Institute (NCI) Identifier:
First received: November 1, 1999
Last updated: December 18, 2013
Last verified: February 2001
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2003
  Estimated Primary Completion Date: No date given
Ledermann JA: Randomised trial of paclitaxel in combination with platinum chemotherapy versus platinum-based chemotherapy in the treatment of relapsed ovarian cancer (ICON4/OVAR2.2). [Abstract] Proceedings of the American Society of Clinical Oncology 22: A-1794, 446, 2003.